TipHub

864.85

+15.88 +1.87%

29 Jul 2026

NSE Listed · Pharmaceuticals

Windlas Biotech Limited (WINDLAS)

Volume: 15,990Avg Vol 1W: 21,042Avg Vol 1M: 44,17152W Range:697.41,097.9
Market Cap₹1,785 Cr
Current Price₹864.85
Previous Close₹848.97
High / Low (52w)₹1,097.9 / ₹697.4
Volume15,990
Avg Vol (1W)21,042
Avg Vol (1M)44,171
Stock P/E26.86
Book Value₹281.35
Dividend Yield74%
ROE11.44%
ROA7.32%
Revenue (TTM)
Revenue Growth20.43%
Profit Margin7.35%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹5
EPS (TTM)₹32.2
P/B3.07
Debt / Equity0.06
50 DMA₹834.88
200 DMA₹820.13
Day change+1.87%
Price Chart
864.85 13.86% · 1Y
107170611.1L
2025-07-29
2026-07-29

20-day avg volume: 45K shares

Pros
  • Pays a dividend yield of 74.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 74% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹175 Cr₹187 Cr₹195 Cr₹203 Cr₹210 Cr₹222 Cr₹233 Cr₹239 Cr
EBITDA₹19 Cr₹21 Cr₹22 Cr₹22 Cr₹24 Cr₹25 Cr₹21 Cr₹22 Cr
Net Profit₹13 Cr₹16 Cr₹16 Cr₹16 Cr₹18 Cr₹18 Cr₹15 Cr₹16 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹195 Cr₹778 Cr₹203 Cr₹210 Cr₹222 Cr₹233 Cr₹239 Cr₹922 Cr
EBITDA₹21 Cr₹84 Cr₹22 Cr₹24 Cr₹25 Cr₹21 Cr₹22 Cr₹92 Cr
Net Profit₹15 Cr₹61 Cr₹16 Cr₹18 Cr₹18 Cr₹15 Cr₹16 Cr₹66 Cr
EPS28.8731.15
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹298 Cr₹338 Cr₹296 Cr₹491 Cr₹529 Cr₹626 Cr₹760 Cr₹907 Cr
Total Liabilities₹105 Cr₹129 Cr₹97 Cr₹96 Cr₹127 Cr₹176 Cr₹255 Cr₹327 Cr
Equity₹194 Cr₹210 Cr₹199 Cr₹395 Cr₹402 Cr₹450 Cr₹506 Cr₹581 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹31 Cr₹38 Cr₹18 Cr₹18 Cr₹71 Cr₹128 Cr₹89 Cr₹120 Cr
Investing₹-5 Cr₹-14 Cr₹-20 Cr₹-155 Cr₹-14 Cr₹-92 Cr₹-74 Cr₹-92 Cr
Financing₹-6 Cr₹-5 Cr₹1 Cr₹130 Cr₹-44 Cr₹-15 Cr₹1 Cr₹-13 Cr
Free Cash Flow₹31 Cr₹38 Cr₹18 Cr₹18 Cr₹71 Cr₹128 Cr₹89 Cr₹120 Cr
Shareholding
Promoter 63.31% Institutions 11.89% Public 24.8%
Efficiency & Working Capital
ROCE14.9%
Interest Coverage19
Dividend Payout
Debtor Days92 d
Inventory Days25 d
Payable Days96 d
Cash Conversion Cycle20 d
Working Capital Days117 d
Shareholding Details

As of 2026-06-30

Promoter63.3%
FII2%
DII9.8%
Institutions11.9%
Public24.8%
Promoter Pledge0%
No. of Shareholders44,996
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026May 2026May 2026Jun 2026
Promoters62.8%62.5%62.5%62.5%62.3%62.3%62%62%61.9%63.3%63.3%63.3%
FIIs1.2%1.6%2%1.6%1.5%1.4%1.1%0.9%0.6%1%1%2%
DIIs11.8%10.3%9.6%10.3%10.9%11.2%11.4%11.4%11.8%10.2%10.2%9.8%
Public24.2%25.6%25.9%25.7%25.3%25%25.5%25.6%25.7%25.5%25.5%24.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders51,27745,82445,70646,59046,38345,88745,43345,46144,76946,08446,08444,996
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Akw Wbl Family Private Trust (through Its Trustees Ashok Vimla Trusteeship Services Private Limited)Shareholding of Promoter and Promoter Group40.6%83,81,340
Ashok Kumar WindlassShareholding of Promoter and Promoter Group21.3%44,00,000
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) FundPublic Shareholding3.4%7,05,991
Mncl Capital Compounder Fund 2Public Shareholding1.7%3,50,000
Bandhan Small Cap FundPublic Shareholding1.4%2,95,367
Vimla WindlasssShareholding of Promoter and Promoter Group1.4%2,84,000
Ajay Kumar AggarwalPublic Shareholding1.2%2,49,138
Perpetuity Health To Wealth (h2w) Rising FundPublic Shareholding1.1%2,29,500
Ashok Kumar Windlass Family TrustShareholding of Promoter and Promoter Group0%0
Vimla Windlass Family TrustShareholding of Promoter and Promoter Group0%0
Windlas FoundationShareholding of Promoter and Promoter Group0%0
Windlas Exports Private LimitedShareholding of Promoter and Promoter Group0%0
Wintech Eco Solutions Private LimitedShareholding of Promoter and Promoter Group0%0
Ashok Vimla Trusteeship Services Private LimitedShareholding of Promoter and Promoter Group0%0
Hitesh WindlassShareholding of Promoter and Promoter Group0%3
Manoj Kumar WindlassShareholding of Promoter and Promoter Group0%3
Payal WindlassShareholding of Promoter and Promoter Group0%3
Prachi Jain WindlassShareholding of Promoter and Promoter Group0%3
Vani Windlass ShuklaShareholding of Promoter and Promoter Group0%0
Rhiditya WindlassShareholding of Promoter and Promoter Group0%0
Atharv WindlassShareholding of Promoter and Promoter Group0%0
Abha JainShareholding of Promoter and Promoter Group0%0
Ankur JainShareholding of Promoter and Promoter Group0%0
Richa MittalShareholding of Promoter and Promoter Group0%0
Ayann WindlassShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Vivek DhariwalChairman & Independent Directo2026
ASHOK KUMAR WINDLASSWTD & Executive Director2026
MANOJ KUMAR WINDLASSJoint MD & Executive Director2026
HITESH WINDLASSExecutive Director & MD2026
Gaurav GulatiIndependent Non Exe. Director2026
Prachi Jain WindlassNon Executive Director2026
Pawan Kumar SharmaExecutive Director2026
Tarashree SinghalIndependent Non Exe. Director2026
Ananta Narayan PandaCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceutical₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹5541111
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-16Dividend (6.3/- per share)Final
dividend2026-07-16₹6.3 (126%)Final
buyback2026-05-07₹1000 max
dividend2025-07-21₹5.8 (116%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202600018523
2026000000
202600014519
Company Information
Incorporated2001
ChairmanVivek Dhariwal
AuditorJ C Bhalla & Co
Investor Email[email protected]
🌐 www.windlasbiotech.com

📍 40/1 Mohabewala Industrial, Area, Dehradun, Uttarakhand, 248110

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search